CD8+ T cell composition at one year after transplant may identify those at higher risk for graft failure
No impact found on transplant referral and evaluation initiation based on distance for ESKD patients
In a study of kidney transplant recipients, mean hemoglobin levels rose from 10.69 g/dL prior to transplantation to 14.45 g/dL at 1 year after transplantation.
Hyperkalemia, hypomagnesemia, and hyperparathyroidism commonly persist after kidney transplant surgery.
Parathyroidectomies for kidney transplant recipients with hyperparathyroidism should be timely and without removal of too much parathyroid hormone to avoid steep drops in intact parathyroid hormone, according to investigators.
Survival up from 1970-1985 to 2005-2015 mainly due to drop in deaths from CV causes, infections.
Cold ischemia time for donor kidneys reduced after implementation of virtual cross-matching program.
In a small study, use of the potassium binder sodium zirconium cyclosilicate in transplant recipient did not appear to compromise immunosuppression with tacrolimus.
For average patient, graft failure will impose medical costs of $78,079 and loss of 1.66 QALYs.
Complete or partial immunosuppressive drug withdrawal without rejection achieved in some.